Hina Qayoom

Srinagar, JK, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Cytochrome c as a central regulator of mitochondrial function in cancer metabolism.

Cytochrome c as a central regulator of mitochondrial function in cancer metabolism.

Journal: Discover oncology

Published: September 15, 2025

Integrative systems biology and in-vitro analysis of cryptolepine's therapeutic role in breast cancer.

Integrative systems biology and in-vitro analysis of cryptolepine's therapeutic role in breast cancer.

Journal: Discover oncology

Published: March 25, 2025

Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies.

Unravelling the therapeutic potential of dual TGFβ-1 and CXCR4 inhibition in breast cancer using computational strategies.

Journal: PloS one

Published: January 13, 2025

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis.

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis.

Journal: Frontiers in pharmacology

Published: September 10, 2024

Mutant P53 modulation by cryptolepine through cell cycle arrest and apoptosis in triple negative breast cancer.

Mutant P53 modulation by cryptolepine through cell cycle arrest and apoptosis in triple negative breast cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 21, 2024

Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis.

Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis.

Journal: Computational biology and chemistry

Published: June 10, 2024

Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.

Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.

Journal: Cell communication and signaling : CCS

Published: March 14, 2024

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors.

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors.

Journal: Frontiers in pharmacology

Published: December 26, 2023

Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.

Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.

Journal: Frontiers in pharmacology

Published: November 08, 2023

Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.

Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.

Journal: Heliyon

Published: October 30, 2023

Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation.

Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation.

Journal: Saudi journal of biological sciences

Published: September 21, 2023

Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation.

Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation.

Journal: Saudi journal of biological sciences

Published: July 14, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026